6.3Fr Versus 7.5Fr Mini-Flexible Ureteroscopy for Renal Stones (MINI-FURS)
MINI-FURS
Outcomes and Cost-Effectiveness of 6.3French vs. 7.5French Mini-Flexible Ureteroscopy in the Treatment of Renal Stones: A Non-Inferiority, Prospective, Randomized, Single-Blinded Study
1 other identifier
interventional
308
1 country
1
Brief Summary
This prospective, randomized, single-blinded, non-inferiority clinical trial will compare the clinical outcomes and cost-effectiveness of two mini-flexible ureteroscopes (6.3Fr and 7.5Fr) used during flexible ureteroscopy for the treatment of renal stones. Adult patients with renal stones up to 15 mm who are scheduled to undergo flexible ureteroscopy will be randomly assigned to one of the two study groups. The primary objectives are to compare stone-free rates and the ability to achieve primary renal access without preoperative ureteral stenting. Secondary outcomes include operative time, fluoroscopy use, ureteral trauma, postoperative stenting, pain, complications, emergency department visits, need for additional procedures, hospital stay, and cost-effectiveness. The results of this study are expected to provide high-quality evidence to guide the selection of mini-flexible ureteroscopes and improve the quality, safety, and value of surgical care for patients with kidney stones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2026
CompletedFirst Posted
Study publicly available on registry
September 1, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 29, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
September 4, 2026
August 1, 2026
1.4 years
August 24, 2026
September 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Stone Free Rate
Stone-free status defined as the absence of residual stone fragments greater than 2 mm on non-contrast CT KUB
1 month after surgery
Primary Renal Access Success Rate
Successful passage of the flexible ureteroscope into the renal collecting system without the need for preoperative ureteral stenting
Perioperative/Periprocedural
Secondary Outcomes (10)
Operative Time
During surgery
Intraoperative Fluoroscopy Use
During surgery
Intraoperative Ureteral Trauma as Assessed by the Traxer Ureteral Injury Scale
Perioperative/Periprocedural
Postoperative Ureteral Stenting Rate
Immediately after surgery
Postoperative Pain as Assessed by the Visual Analog Scale
6, 24, and 48 hours after surgery
- +5 more secondary outcomes
Study Arms (2)
6.3Fr Mini-Flexible Ureteroscope
EXPERIMENTALParticipants randomized to this arm will undergo flexible ureteroscopy using a 6.3Fr mini-flexible ureteroscope for the treatment of renal stones according to the study protocol
7.5Fr Mini-Flexible Ureteroscope
ACTIVE COMPARATORParticipants randomized to this arm will undergo flexible ureteroscopy using a 7.5Fr mini-flexible ureteroscope for the treatment of renal stones according to the study protocol
Interventions
Use of a disposable 6.3Fr mini-flexible ureteroscope during flexible ureteroscopy for renal stone treatment
Use of a disposable 7.5Fr mini-flexible ureteroscope during flexible ureteroscopy for renal stone treatment
Eligibility Criteria
You may qualify if:
- Scheduled to undergo flexible ureteroscopy for renal stones.
- Renal stone size ≤15 mm in the greatest dimension.
- No indwelling ureteral stent at the time of surgery.
- Able and willing to provide written informed consent.
You may not qualify if:
- Anatomical abnormalities of the urinary tract (e.g., ureteral stricture, horseshoe kidney, ectopic kidney).
- Solitary kidney.
- Pregnancy.
- Stones located within a calyceal diverticulum.
- Any condition that, in the opinion of the investigator, would interfere with study participation or follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sault Area Hospital
Sault Ste. Marie, Ontario, P6B 0A8, Canada
Related Publications (7)
Ebner B, Blajan I, Westphal JR, Papadopoulos I, Ivanova T, Karatas D, Happe M, Volz Y, Stief CG, Apfelbeck M, Chaloupka M. Feasibility and Safety of Primary Ureteroscopy with Single-Use Flexible Ureteroscope HU30M (6.3 Fr, HugeMed): An Initial Experience. Diagnostics (Basel). 2025 Oct 5;15(19):2522. doi: 10.3390/diagnostics15192522.
PMID: 41095741BACKGROUNDGeavlete B, Ene C, Iordache V, Geavlete P. Initial Experience with the New Super Thin Single-use Pusen Flexible Ureteroscope 7.5 Fr in Renal Stones Endoscopic Treatment. Chirurgia (Bucur). 2021 May-Jun;116(3):354-360. doi: 10.21614/chirurgia.116.3.354.
PMID: 34191717BACKGROUNDHu H, Qin M, Yang L, Hu H, Qin G, Qiu M, Gao Y, Dou J, Wu T, Long P, Zhang W. Analysis of the effectiveness and safety of 7.5 Fr ultra-thin flexible ureteroscope combined with a tip-flexible suctioning ureteral access sheath for the treatment of kidney stones. Int Urol Nephrol. 2025 Mar;57(3):817-823. doi: 10.1007/s11255-024-04269-1. Epub 2024 Nov 9.
PMID: 39521733BACKGROUNDGeavlete PA, Bulai CA, Multescu RD, Ene CV, Militaru A, Punga AA, Geavlete BF. Early clinical outcomes using a 6.3 Fr single use ureteroscope compared to a 7.5 Fr device. Sci Rep. 2025 May 2;15(1):15362. doi: 10.1038/s41598-025-00515-3.
PMID: 40316636BACKGROUNDAlharran AM, Alajmi SA, Hussain AA, Alajmi MS, Hashim S, Alwazzan LT, Alaradi H. Efficacy and Safety of 6.3 Fr Versus 7.5 Fr Single-Use Flexible Ureteroscopes for Upper Urinary Tract Stones: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina (Kaunas). 2025 Nov 26;61(12):2103. doi: 10.3390/medicina61122103.
PMID: 41470105BACKGROUNDAssimos DG. Urolithiasis/Endourology. J Urol. 2021 Sep;206(3):765-767. doi: 10.1097/JU.0000000000001904. Epub 2021 Jun 11. No abstract available.
PMID: 34111940BACKGROUNDZhang L, Zhang X, Pu Y, Zhang Y, Fan J. Global, Regional, and National Burden of Urolithiasis from 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Clin Epidemiol. 2022 Aug 15;14:971-983. doi: 10.2147/CLEP.S370591. eCollection 2022.
PMID: 35996396BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yasser A Noureldin, MD, PhD
Urologist, Sault Area Hospital, Sault Ste. Marie, ON, Canada, and Assistant Professor of Urology, Northern Ontario School of Medicine University, ON, Canada
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and outcome assessors, including staff collecting postoperative outcomes and radiologists evaluating imaging studies, will be blinded to treatment allocation. Operating surgeons and operating room personnel will not be blinded because they must know which ureteroscope is being used during the procedure
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2026
First Posted
September 1, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
February 29, 2028
Study Completion (Estimated)
August 31, 2028
Last Updated
September 4, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made available to other researchers. This decision reflects applicable institutional policies, participant privacy and confidentiality requirements, ethical considerations, and the terms of informed consent. De-identified aggregate study results will be reported in accordance with applicable reporting requirements.